Brief: Wanbury Expanded Regulatory Submission For New Active Pharmaceutical Ingredients
09/06/2026 10:39
BRIEF-Wanbury Expanded Regulatory Submission For New Active Pharmaceutical Ingredients June 9 (Reuters) - Wanbury Ltd WANB.NS:
WANBURY - EXPANDED REGULATORY SUBMISSION FOR NEW ACTIVE PHARMACEUTICAL INGREDIENTS
WANBURY LTD - FOR DIPHENHYDRAMINE HCL, COMPANY SUBMITTED DMF TO MALAYSIA AND SINGAPORE
WANBURY - TO SUBMIT DMFS FOR PAROXETINE HCL IN KOREA AND LATIN AMERICA
Source text: ID:nBSE6ZP8yc
Further company coverage: WANB.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Wanbury
See all newsBrief: Wanbury Says Tanuku API Site Completes TGA Quality Inspection
Brief: Wanbury Expanded Regulatory Submission For New Active Pharmaceutical Ingredients
Brief: Wanbury Says Patalganga Site Has Completed Korea FDA Regulatory Inspection Successfully
Brief: Wanbury Ltd Launches Coriminic CPM Drops For Pediatric Use
Brief: Wanbury Receives Sertraline Form II Approval From Anvisa, Brazil